DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA

pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or m...

Full description

Saved in:
Bibliographic Details
Main Authors Claremon, David A, Dong, Chengguo, Marcus, Andrew, Yuan, Jing, Lotesta, Stephen D, Zhao, Wei, Zhuang, Linghang, Dillard, Lawrence Wayne, Singh, Suresh B, Tice, Colin M, Fan, Yi
Format Patent
LanguageEnglish
Published 12.03.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
Bibliography:Application Number: US201916394764